Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × mCRC × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 104 Neoplasm Metastasis 68 Colorectal Neoplasms 62 Neoplasms 61 Breast Neoplasms 60 Leukemia, Myeloid, Acute 56 Ovarian Neoplasms 54 Melanoma 46 Recurrence 45 Multiple Myeloma 44 Prostatic Neoplasms 43 Squamous Cell Carcinoma of Head and Neck 42 Triple Negative Breast Neoplasms 38 Lung Neoplasms 38 Pancreatic Neoplasms 35 Lymphoma, Non-Hodgkin 32 Endometrial Neoplasms 32 Stomach Neoplasms 30 Myelodysplastic Syndromes 30 Glioblastoma 27 Carcinoma, Renal Cell 26 Small Cell Lung Carcinoma 25 Urinary Bladder Neoplasms 24 Lymphoma, Large B-Cell, Diffuse 23 Carcinoma, Hepatocellular 22 Hematologic Neoplasms 21 Glioma 20 Lymphoma, Follicular 19 Esophageal Neoplasms 19 Carcinoma, Transitional Cell 18

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07543471 2026-04-21

PK equivalence

Shanghai Henlius Biotech

Phase 1 Not yet recruiting

mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡